Smol International Releases 2022 Half-Year Performance Report

Aug.24.2022
Smol International Releases 2022 Half-Year Performance Report
Semiconductor company SMIC reported solid H1 2022 earnings of CNY 56.5 billion, driven by innovation and diversification.

On August 24th, Semiconductors International (06969) released its financial report for the first half of 2022. The company reported a revenue of RMB 5.65 billion and an adjusted net profit of RMB 1.44 billion.


In the first half of 2022, Chen Zhiping, Chairman of the Board of Directors of Sumitomo International, expressed the company's commitment to long-term thinking in the face of an ever-changing and challenging external environment. The company will continue to invest in the future and adhere to its long-term philosophy. Scientific and technological innovation is the driving force of Sumitomo's development, and only by adhering to innovation can the company build long-term competitiveness and create long-term value for the country, customers, employees, and shareholders.


The US market helps clients become number one, while the Chinese market actively supports regulation.


The financial report reveals that from January to June 2022, Simore's operating income was 5.65 billion and adjusted net profit was 1.44 billion.


Behind the stable revenue is SMOORE's active layout in the electronic atomization market and the diversity of its income distribution. According to data, in the first half of the year, SMOORE's enterprise customer business (ODM) and retail customer business (APV) grew rapidly in Europe. In terms of revenue for the first half of the year, the proportion of income from countries and regions outside of China and the United States was 39%, an increase of 16 percentage points compared to the same period last year, which was 23%.


In the US market, Smoore, with its technological and manufacturing advantages, has become a leading manufacturer of ENDS (electronic nicotine delivery systems) that assists many customers to pass PMTA (premarket tobacco product application). Additionally, Smoore has helped its customers gain market share by offering reasonable prices. It is expected that the company will maintain stable and healthy orders throughout the second half of the year.


In the Chinese market, Smoore supports regulatory policies. The current planning and regulation by the National Tobacco Monopoly Administration marks a new starting point for industry development in accordance with regulations. Smoore strictly adheres to regulatory requirements and actively applies for tobacco monopoly production licenses. Currently, three subsidiaries have already been granted production licenses. Smoore will continue to strengthen research and development of products that meet national standards to meet regulatory requirements and provide consumers with a better experience. At the same time, it will ensure the delivery of products that meet national standards from the manufacturing end.


Research and development investment has increased significantly by 156%, as the company continues to focus on internal innovation to build its core competitiveness.


Chen Zhiping stated that on the path of creating a globally leading atomization technology platform, it is impossible to have a completely smooth journey. We will continue to believe in the promising future of atomization technology, persist in invention and innovation, and remain committed to a long-term strategy.


As a result, SiMoEr has been increasing their research and development investment according to their planned schedule. They are focusing particularly on areas such as basic research, new materials research, and atomization medical treatment in order to improve their talent density, establish a global research and development system, and build their core competitiveness. In the first half of the year, their research and development expense was 604 million yuan, which is a 156% increase compared to the same period last year.


During the first half of the year, 14 basic research institutes were put into operation globally, with several important scientists and hundreds of masters and doctoral students from renowned universities joining the company. As of June 30th, there were 1,472 R&D experts at SMIC, accounting for over 40% of the total R&D personnel.


Top talent joining has enabled Semler to further cultivate core technology and build a core patent barrier. Currently, there are 4,337 patent applications globally, with 929 newly added applications in the first half of this year. In April of this year, "Semler's launch of a 337 rights protection investigation in the US" was consecutively selected as one of the top ten intellectual property events in Guangdong Province and Shenzhen City in 2021.


Medical atomization products smoothly enter domestic approval channel.


In the field of medical nebulization, Simoer has established a wholly-owned subsidiary in the United States to focus on the research and development of respiratory drug products, providing relief for patients with asthma and chronic obstructive pulmonary disease. Currently, they have reached an agreement with one of the world's largest pharmaceutical manufacturing companies to develop two nebulized drugs. If the products are approved smoothly, they are expected to be launched in the next few years.


In addition, Simoer's first domestic research and development of a nebulizer device is currently going through the approval process in China.


In the first half of the year, exports generated 3.955 billion yuan in foreign exchange earnings. The four major directions for reducing carbon emissions were announced as a priority.


As a "dream chaser with love", Si Moer continuously responds to public expectations and practices corporate social responsibility through concrete actions.


In the first half of the year, SMIC generated 3.955 billion USD in foreign exchange earnings by exporting to overseas markets. To address the challenging situation of over 10 million university graduates in 2022, SMIC has established deep school-enterprise cooperation relationships with 15 colleges and universities, cultivating and supplying over 1,000 skilled workers to the industry. Additionally, SMIC is actively implementing talent management programs, such as "SMIC model talent" and "SMIC skilled talent," targeting graduates in 2022 and 2023.


In addition, as the first vaporization technology company to list a carbon neutrality schedule, Simoer has released its carbon reduction targets and plans to achieve carbon neutrality within scopes 1 and 2 by 2050. Data shows that in 2021, Simoer has achieved a year-on-year decrease in greenhouse gas emissions density of about 16% and a year-on-year reduction in water consumption density of about 9.4%.


During the first half of the year, semiconductor company SMIC was able to maintain its A-grade rating in ESG evaluations published by MSCI, the world's largest index provider. Additionally, SMIC was awarded five major prizes, including the award for corporate governance (ESG), in the 2022 Asia Management Team selection.


This article includes excerpts or reprints of information from third-party sources. Copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual who wishes to reprint must contact the author. Please do not directly repost.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania begins enforcing its electronic nicotine delivery system (ENDS) directory restrictions on October 19, 2026. The October 18 directory contained 163 product records from seven manufacturers, including Vuse, JUUL, NJOY, Logic and Naked 100. Geek Bar, RAZ and Lost Mary were absent. BAT, Altria, Japan Tobacco and JUUL collectively accounted for 112 records, or 68.7%, while Imperial Brands' blu had no listings. The directory included 15 disposable vape records, 40 bottled e-liquids and 10 products labeled 0mg, but no open-system refillable devices. Twenty-two manufacturer certifications remained under review. Four Logic models corresponding to Smoore's pending records were listed under the brand owner, while LYCO, OXBAR and Boulder/Rock had no approved directory entries.
Regulations
Oct.19
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04